Werfen: FDA 510(k) clearances across all its applicant names
FDA lists 523 510(k) clearances, 0 PMA and 3 De Novo decisions across the 8 applicant names Caduvo groups under Werfen, first 1976, latest 2026. Median 510(k) review time across these names: 73 days. Since 2017 the median was 119 days, against 173 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 4 | 237 |
| 2013 | 5 | 225 |
| 2014 | 5 | 169 |
| 2015 | 10 | 257 |
| 2016 | 12 | 260 |
| 2017 | 8 | 216 |
| 2018 | 3 | 73 |
| 2019 | 6 | 58 |
| 2020 | 4 | 158 |
| 2021 | 5 | 518 |
| 2022 | 3 | 299 |
| 2023 | 9 | 251 |
| 2024 | 2 | 418 |
| 2025 | 2 | 59 |
| 2026 | 3 | 30 |
The 8 FDA applicant names in this group
| Applicant name | 510(k) clearances | PMA | De Novo | Years |
|---|---|---|---|---|
| Instrumentation Laboratory CO | 323 | 0 | 1 | 1976–2023 |
| Inova Diagnostics, Inc. | 136 | 0 | 2 | 1988–2026 |
| International Technidyne Corp. | 48 | 0 | 0 | 1983–2013 |
| Instrumentation Laboratory (IL) Co. | 5 | 0 | 0 | 2024–2026 |
| Accriva Diagnostics, Inc. | 3 | 0 | 0 | 2019–2023 |
| Immucor, Inc. | 3 | 0 | 0 | 1991–2021 |
| Instrumentation Laboratory Company | 3 | 0 | 0 | 2023–2023 |
| Immucor Gti Diagnostics, Inc. | 2 | 0 | 0 | 2020–2020 |
Review time against the same product codes
Since 2017, 510(k)s cleared under these names took a median 119 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 173 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| LLL | Extractable Antinuclear Antibody, Antigen And Control | 37 | 37 |
| GGP | Test, Qualitative And Quantitative Factor Deficiency | 28 | 28 |
| JPA | System, Multipurpose For In Vitro Coagulation Studies | 23 | 23 |
| GJS | Test, Time, Prothrombin | 19 | 19 |
| CHL | Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph | 16 | 16 |
| GGN | Plasma, Coagulation Control | 12 | 12 |
| MVM | Autoantibodies, Endomysial(Tissue Transglutaminase) | 12 | 12 |
| GKP | Instrument, Coagulation, Automated | 11 | 11 |
| DAP | Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control | 10 | 10 |
| GFO | Activated Partial Thromboplastin | 10 | 10 |
Plus 176 more product codes.
Review panels
- Hematology (178)
- Immunology (152)
- Clinical Chemistry (119)
- Clinical Toxicology (35)
- Microbiology (16)
- Cardiovascular (14)
- Anesthesiology (4)
- General and Plastic Surgery (4)
Most recent Werfen 510(k) clearances
| 510(k) | Device | Applicant name | Product code | Decision date | Review days |
|---|---|---|---|---|---|
| K260551 | HemosIL Factor V Leiden (APC Resistance V) | Instrumentation Laboratory (IL) Co. | GGW | 2026-03-20 | 30 |
| K243979 | Aptiva APS IgA Reagent | Inova Diagnostics, Inc. | MSV | 2026-02-06 | 410 |
| K253957 | HemosIL Silica Clotting Time | Instrumentation Laboratory (IL) Co. | GFO | 2026-01-09 | 30 |
| K251968 | HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XL | Instrumentation Laboratory (IL) Co. | KQJ | 2025-07-24 | 28 |
| K243374 | HemosIL CL HIT-IgG(PF4-H) | Instrumentation Laboratory (IL) Co. | LCO | 2025-01-28 | 90 |
| K223093 | Aptiva APS IgG Reagent; Aptiva APS IgM Reagent | Inova Diagnostics, Inc. | MID | 2024-12-17 | 809 |
| K242127 | ACL TOP Family 50 Series (ACL TOP 750; ACL TOP 750 CTS; ACL TOP 750 LAS; ACL TOP 550 CTS; ACL TOP 350 CTS) | Instrumentation Laboratory (IL) Co. | GKP | 2024-08-16 | 28 |
| K233790 | ACL TOP 970 CL | Instrumentation Laboratory CO | JPA | 2023-12-29 | 31 |
| K230852 | HemosIL Chromogenic Factor IX | Instrumentation Laboratory Company | GGP | 2023-12-13 | 260 |
| K221359 | ACL TOP 970 CL, HemosIL CL Anti-Cardiolipin IgM, HemosIL CL Anti-ß2 Glycoprotein-I IgM | Instrumentation Laboratory CO | JPA | 2023-09-29 | 506 |
513 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| DEN190032 | De Novo | Anti-Factor Xa Activity Test System, Apixaban | 2020-09-17 |
| DEN140039 | De Novo | Automated Indirect Immunofluorescence Microscope And Software-Assisted System For Clinical Use | 2015-04-09 |
| DEN000007 | De Novo | Antibodies, Saccharomyces Cerevisiae (S.Cerevisiae) | 2000-08-16 |
Recalls
132 product recalls in 60 recall events under these names; 49 initiated in the last five years.
Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
How this group is built
Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
Werfen owns Instrumentation Laboratory (since 1991), Inova Diagnostics (2008), Accriva (formerly ITC, 2017) and Immucor (completed March 15, 2023). Includes filings made before each acquisition.
Sources
- https://en.wikipedia.org/wiki/Werfen
- https://www.werfen.com/en/werfen-completes-acquisition-immucor-inc-expanding-leadership-specialized-diagnostics-0
Frequently asked questions
How many FDA 510(k) clearances are listed across Werfen's applicant names?
FDA lists 523 510(k) clearances, 0 PMA and 3 De Novo decisions across the 8 applicant names Caduvo groups under Werfen, first 1976, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.
Which FDA applicant names does Werfen file under?
The names with the most 510(k) clearances in this group are Instrumentation Laboratory CO (323); Inova Diagnostics, Inc. (136); International Technidyne Corp. (48); Instrumentation Laboratory (IL) Co. (5); Accriva Diagnostics, Inc. (3). The full list of 8 names is on this page.
How long does FDA take to clear Werfen 510(k)s?
The median time from FDA receipt to decision across 510(k)s cleared under these names is 73 days. Since 2017 the median was 119 days, against 173 days for all cleared 510(k)s in the same product codes.
Does the Werfen count include acquired companies?
Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.
Next steps
- See all 523 Werfen clearances with predicates and recalls
- Run predicate analysis for product code LLL, Werfen's most frequent
Data from openFDA (510(k), PMA, De Novo, device recalls). Applicant names are matched exactly, with punctuation and legal suffixes removed. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this grouping or data.
All parent companies · FDA device companies by applicant name · FDA product code lookup